Acute cardiac decompensation in a patient with beta‐thalassemia and diabetes mellitus following cessation of chelation therapy

Patients with higher liver iron stores are likely to have a worse cardiac outcome following noncompliance with chelation. Cardiovascular magnetic resonance identifies myocardial siderosis allowing optimization of iron chelation regimes. Diabetes puts thalassemic patients at increased risk of myocard...

Descripción completa

Detalles Bibliográficos
Autores principales: Lioudaki, Eirini, Whyte, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054478/
https://www.ncbi.nlm.nih.gov/pubmed/27761254
http://dx.doi.org/10.1002/ccr3.686
_version_ 1782458608369270784
author Lioudaki, Eirini
Whyte, Martin
author_facet Lioudaki, Eirini
Whyte, Martin
author_sort Lioudaki, Eirini
collection PubMed
description Patients with higher liver iron stores are likely to have a worse cardiac outcome following noncompliance with chelation. Cardiovascular magnetic resonance identifies myocardial siderosis allowing optimization of iron chelation regimes. Diabetes puts thalassemic patients at increased risk of myocardial fibrosis. Dual chelation therapy with deferoxamine and deferiprone offers improved cardiac outcomes.
format Online
Article
Text
id pubmed-5054478
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50544782016-10-19 Acute cardiac decompensation in a patient with beta‐thalassemia and diabetes mellitus following cessation of chelation therapy Lioudaki, Eirini Whyte, Martin Clin Case Rep Case Reports Patients with higher liver iron stores are likely to have a worse cardiac outcome following noncompliance with chelation. Cardiovascular magnetic resonance identifies myocardial siderosis allowing optimization of iron chelation regimes. Diabetes puts thalassemic patients at increased risk of myocardial fibrosis. Dual chelation therapy with deferoxamine and deferiprone offers improved cardiac outcomes. John Wiley and Sons Inc. 2016-09-12 /pmc/articles/PMC5054478/ /pubmed/27761254 http://dx.doi.org/10.1002/ccr3.686 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Lioudaki, Eirini
Whyte, Martin
Acute cardiac decompensation in a patient with beta‐thalassemia and diabetes mellitus following cessation of chelation therapy
title Acute cardiac decompensation in a patient with beta‐thalassemia and diabetes mellitus following cessation of chelation therapy
title_full Acute cardiac decompensation in a patient with beta‐thalassemia and diabetes mellitus following cessation of chelation therapy
title_fullStr Acute cardiac decompensation in a patient with beta‐thalassemia and diabetes mellitus following cessation of chelation therapy
title_full_unstemmed Acute cardiac decompensation in a patient with beta‐thalassemia and diabetes mellitus following cessation of chelation therapy
title_short Acute cardiac decompensation in a patient with beta‐thalassemia and diabetes mellitus following cessation of chelation therapy
title_sort acute cardiac decompensation in a patient with beta‐thalassemia and diabetes mellitus following cessation of chelation therapy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054478/
https://www.ncbi.nlm.nih.gov/pubmed/27761254
http://dx.doi.org/10.1002/ccr3.686
work_keys_str_mv AT lioudakieirini acutecardiacdecompensationinapatientwithbetathalassemiaanddiabetesmellitusfollowingcessationofchelationtherapy
AT whytemartin acutecardiacdecompensationinapatientwithbetathalassemiaanddiabetesmellitusfollowingcessationofchelationtherapy

Ejemplares similares